These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6440661)

  • 1. The masking of amine accumulation by catecholamine depletion.
    Willis GL; Smith GC; McGrath B
    Brain Res; 1984 Dec; 324(1):43-50. PubMed ID: 6440661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioural effects of intrahypothalamic multistage versus single injections of 6-hydroxydopamine.
    Willis GL; Smith GC
    Brain Res; 1982 Aug; 245(2):345-52. PubMed ID: 6812852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and pharmacological basis for the lateral hypothalamic syndrome.
    Singer G; Willis GL
    Brain Res Bull; 1977; 2(6):485-9. PubMed ID: 272222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microspectrofluorometric characterization of amine accumulation proximal to lateral hypothalamic lesions.
    Willis GL; Wreford NG; Smith GC
    Brain Res; 1985 May; 334(2):344-7. PubMed ID: 3922566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amine accumulation in behavioural pathology.
    Willis GL; Smith GC
    Brain Res; 1985 Jun; 356(2):109-32. PubMed ID: 3924349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial injections of 6-OHDA. Comparison of catecholamine-depleting effects of different volumes and concentrations.
    Willis GL; Singer G; Evans BK
    Pharmacol Biochem Behav; 1976 Aug; 5(2):207-13. PubMed ID: 996052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of insulin binding in the arcuate nucleus of the rat hypothalamus after 6-hydroxydopamine treatment.
    Wilcox BJ; Matsumoto AM; Dorsa DM; Baskin DG
    Brain Res; 1989 Oct; 500(1-2):149-55. PubMed ID: 2514006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of neonatal 6-hydroxydopamine administration on the catecholaminergic structures of the hypothalamus and on the behavior of rats of various ages].
    Konstantinova MS; Semenova TP; Grishchenko NI; Gromova EA; Polenov AL
    Ontogenez; 1989; 20(3):332-6. PubMed ID: 2549482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The amine accumulation-producing capacity of 6-hydroxydopamine and its neurochemical specificity.
    Willis GL; Smith GC
    Brain Res Bull; 1986 Aug; 17(2):145-9. PubMed ID: 3094834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food intake and biogenic amine concentrations in brain regions of chicks following intracerebroventricular injection of six-hydroxydopamine.
    Kuenzel WJ; Snapir N; Rexroad CE
    Pharmacol Biochem Behav; 1987 Jun; 27(2):257-63. PubMed ID: 3114769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine-blocking drugs injected at sites of amine accumulation reverse catecholamine degeneration associated deficits.
    Willis GL; Smith GC
    Behav Brain Res; 1985 Apr; 15(2):101-6. PubMed ID: 3922388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of intracranial injections of 6-OHDA and guanethidine on consummatory behavior and monoamine depletion.
    Singer G; Armstrong S; Evans B; Burnstock G
    Pharmacol Biochem Behav; 1975; 3(1 Suppl):91-106. PubMed ID: 1226403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of ibotenic acid and 6-hydroxydopamine lesions of the lateral hypothalamus on intracranial self-stimulation and stimulation-induced locomotion.
    Velley L; Verney C; Kempf E; Berger B
    Neuroscience; 1988 May; 25(2):595-603. PubMed ID: 3135510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular, paraventricular and circumventricular structures involved in peptide-induced satiety.
    Willis GL; Hansky J; Smith GC
    Regul Pept; 1984 Sep; 9(1-2):87-99. PubMed ID: 6095374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for amine accumulation in the syndrome of ingestive deficits following lateral hypothalamic lesions.
    Willis GL; Smith GC
    Appetite; 1984 Sep; 5(3):239-67, 277-9. PubMed ID: 6441517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of acute and chronic treatment with triiodothyronine and thyroxine on the hypothalamic and telencephalic catecholamine nerve terminal systems of the hypophysectomized male rat. Chronic treatment modulates catecholamine utilization in discrete catecholamine nerve terminal systems.
    Andersson K; Eneroth P
    Neuroendocrinology; 1985 May; 40(5):398-408. PubMed ID: 4010888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional brain catecholamine levels and the development of hypertension in the spontaneously hypertensive rat: the effect of 6-hydroxydopamine.
    van den Buuse M; de Kloet ER; Versteeg DH; de Jong W
    Brain Res; 1984 Jun; 301(2):221-9. PubMed ID: 6428702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feeding behavior after hypothalamic 6-hydroxydopamine injections.
    Leibowitz SF
    Appetite; 1984 Sep; 5(3):268-71. PubMed ID: 6441518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.